Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2016
At a glance
- Drugs Anagliptin (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 13 Aug 2013 Status changed from not stated to recruiting.
- 13 Aug 2013 New trial record